Unit for Thrombosis Research, Department of Regional Health Research, University of Southern, Esbjerg, Denmark.
Department of Clinical Biochemistry, University Hospital of Southern Denmark, Esbjerg, Denmark.
Thromb Haemost. 2021 Oct;121(10):1268-1273. doi: 10.1055/a-1346-3384. Epub 2021 Feb 28.
The effect of anabolic-androgenic steroid (AAS) abuse on the contact activation system (CAS) is not known in detail. We hypothesized that current AAS abuse reduces the kallikrein-generating capacity of CAS significantly and investigated the impact of AAS on the proteins and capacity of CAS in current and former AAS abusers and healthy age-matched controls. Men 18 to 50 years of age were included as current AAS abusers, former AAS abusers, or controls. Blood samples were collected after overnight fasting. Kallikrein generation (lag time, peak height, and endogenous kallikrein potential [EKP]), coagulation factor XII (FXII), prekallikrein, high-molecular-weight kininogen (HK), and Complement C1 esterase inhibitor (C1inh) were assessed. Groups were compared by analysis of variance or Kruskal-Wallis test and probabilities were corrected for multiple comparisons. Associations were evaluated by linear regression models. The EKP was significantly reduced in current ( = 37) AAS abusers (984 ± 328 nmol/L × min) compared with former ( = 33) abusers (1,543 ± 481 nmol/L × min) and controls ( = 30) (1,521 ± 339 nmol/L × min), < 0.001. Current abusers had higher levels of FXII and C1inh and lower levels of prekallikrein and HK than controls, ≤ 0.025. Stepwise regression analysis showed that EKP was associated with C1inh and prekallikrein in current AAS abusers, = 0.70, < 0.001. We conclude that current AAS abuse reduces the kallikrein-generating capacity of CAS by increasing the concentration of C1inh and reducing the concentration of prekallikrein. These changes may contribute to the anti-inflammatory effect of testosterone.
目前尚不清楚合成代谢雄激素类固醇(AAS)滥用对接触激活系统(CAS)的影响。我们假设,目前的 AAS 滥用会显著降低 CAS 的激肽生成能力,并研究 AAS 对当前和以前的 AAS 滥用者以及年龄匹配的健康对照组中 CAS 的蛋白和能力的影响。18 至 50 岁的男性被纳入当前的 AAS 滥用者、以前的 AAS 滥用者或对照组。采集过夜禁食后的血液样本。评估激肽生成(滞后时间、峰值高度和内源性激肽潜能[EKP])、凝血因子 XII(FXII)、前激肽、高分子量激肽原(HK)和补体 C1 酯酶抑制剂(C1inh)。通过方差分析或 Kruskal-Wallis 检验比较组间差异,并对多重比较进行概率校正。通过线性回归模型评估相关性。与以前的 AAS 滥用者( = 33)和对照组( = 30)相比,当前的 AAS 滥用者( = 37)的 EKP 明显降低(分别为 984 ± 328 nmol/L × min 和 1,543 ± 481 nmol/L × min), < 0.001。与对照组相比,当前的 AAS 滥用者的 FXII 和 C1inh 水平较高,而前激肽和 HK 水平较低, ≤ 0.025。逐步回归分析显示,EKP 与当前 AAS 滥用者的 C1inh 和前激肽呈正相关, = 0.70, < 0.001。我们得出结论,当前的 AAS 滥用通过增加 C1inh 的浓度和降低前激肽的浓度来降低 CAS 的激肽生成能力。这些变化可能有助于睾酮的抗炎作用。